Drug Topics e-News:

Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Subscribe Now

to Drug Topics e-News

Drug Topics, Voice of the Pharmacist
Part of the Modern Medicine Network

e-News

DrugTopics.com

March 03, 2011

Drug Topics
Home CE DT Blog JP at Large Viewpoints Regulatory and Legal Archives
In This Issue
BP meds don't benefit stroke
DT Blog: FDA is no Nanny
TXA reduces death from bleeding
Sunitinib and everolimus show promise for tumors
Antipsychotic drug use reduced in dementia
2012 White House Budget
Continuing Education
Newest: Medication errors: Causes, prevention, liability, and the apology
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here
Meetings
Survey
Last month's survey results...

As a pharmacist, do you ever advise patients to split pills to save on costs?
Pie-Chart
• Yes 61%

• No 39%
This month we would like to know...

Does your pharmacy use social media (blog, Facebook, Twitter, etc.) as a marketing tool?
• Yes

• No

• We plan on using social media in 2011
Click Here to Vote

Digital Edition

Drug Topics Digital Edition View Current Edition Subscribe to the Digital Edition

BP medication does not benefit stroke patients

A new study published in The Lancet found that medication for lowering blood pressure in hypertensive stroke patients might be harmful and has little benefit.
Read full article.

divider

DT Blog

Melissa

A discussion generated by Drug Topics' readers, editorial staff, and advisory board
Jim Plagakis is a community pharmacist in Galveston, Texas.

Untie the apron strings: FDA no 'Nanny'
Read full article.

divider

TXA reduces death from bleeding
in trauma patients

Tranexamic acid reduces the risk of death from bleeding without increasing the risk of vascular occlusive events or the need for surgical intervention, according to a review published in the 2011 Cochrane Database of Systematic Reviews. Read full article.

divider

Two drugs show promise in advanced pancreatic neuroendocrine tumors

Sunitinib and everolimus improved progression-free survival in patients with advanced pancreatic neuroendocrine tumors, according to 2 recent studies published in the New England Journal of Medicine.
Read full article.

divider

Black box warnings accelerate reduced antipsychotic use in dementia

The rate of decline in the use of atypical antipsychotics in outpatients with dementia accelerated following a black box warning issued by FDA, according to "Trends in Antipsychotic Use in Dementia 1999-2007," a multicenter study of national Veterans Affairs data that appeared in the Archives of General Psychiatry.
Read full article.

divider

2012 Budget seeks more safety, faster access to lower-cost drugs

In the White House Budget, President Barack Obama targets the high cost of prescription drugs and proposes 2 significant changes for improving consumer access to
less-expensive generic drugs. Read full article.

divider

Meetings and Events

March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]

March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

March 14-17, 2011 The 35th International Good Manufacturing Practices Conference
On spotlighting GMP enforcement
Athens, GA
Contact:
Gary Dykstra
678-985-6827
[email protected]

March 24, 2011 Regional NACDS-DEA Meeting
10:00 a.m.-3:00 p.m.
Houston, Texas
Contact:
Magalie Normil
413 North Lee Street
Alexandria, VA 22313-1480
[email protected]

March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734

CEC

Connect to Us

Twitter Follow Us on Twitter
Congratulations to Shawn Ackerman, Walgreens, Bristol, R.I., for winning the $100 gift card for participating in the January Drug Topics' reader survey.
Contact Us Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Healthcare

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.